| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alise Reicin | Chief Executive Officer | 2025-12-31 | 10,966 | $2.38 | $26.10kBuy |
| Peter McNamara | Chief Scientific Officer | 2025-12-22 | 7,000 | $2.98 | $20.86kBuy |
| Alise Reicin | Chief Executive Officer | 2025-06-20 | 859 | $19.81 | $17.02kSell |
| Timothy A. Springer | Director | 2025-04-11 | 9,478 | $16.31 | $154.59kBuy |
| Timothy A. Springer | Director | 2025-04-11 | 53,706 | $16.31 | $875.94kBuy |
| Timothy A. Springer | Director | 2025-04-10 | 8,092 | $16.73 | $135.38kBuy |
| Timothy A. Springer | Director | 2025-04-10 | 45,858 | $16.73 | $767.20kBuy |
| Timothy A. Springer | Director | 2025-04-09 | 857 | $15.23 | $13.05kBuy |
| Timothy A. Springer | Director | 2025-04-09 | 2,861 | $14.62 | $41.83kBuy |
| Timothy A. Springer | Director | 2025-04-09 | 16,215 | $14.62 | $237.06kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Timothy A. Springer | 32.19% | 6,024,338 | $138.20M | Insider |
| Bruce Booth | 29.75% | 5,567,289 | $127.71M | Insider |
| Braden Michael Leonard | 26.21% | 4,905,068 | $112.52M | Insider |
| Atlas Venture Fund X LP | 25.41% | 4,756,478 | $109.11M | Insider |
| Clarus Lifesciences III LP | 23.74% | 4,443,487 | $101.93M | Insider |
| Atlas Venture Associates X LP | 19.82% | 3,710,052 | $85.11M | Insider |
| Scott Requadt | 15.83% | 2,962,325 | $67.96M | Insider |
| Blackstone Holdings II LP | 15.83% | 2,962,325 | $67.96M | Insider |
| Fmr LLC | 15.00% | 2,806,781 | $64.39M | Institution |
| Blackrock Inc | 4.42% | 827,853 | $18.99M | Institution |